Hematologic and molecular response to ropeginterferon alfa-2b in patients with polycythemia vera: a systematic review and meta-analysis

Abstract Ropeginterferon alfa-2b is an interferon used in the treatment of myeloproliferative neoplasms, particularly polycythemia vera. Its efficacy in achieving hematologic and molecular responses has been demonstrated in clinical trials, but pooled data on long-term outcomes and sustained respons...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ammar Elgadi, Mohammed Wagealla, Tibyan Noorallah, Rayan Esmail, Shafee S. Almahi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer 2026-05-01
Edice:	Annals of Hematology
Témata:	Ropeginterferon alfa-2b Polycythemia vera Complete hematologic response (CHR) Molecular response JAK2V617F variant allele frequency (VAF) Myeloproliferative neoplasms (MPN)
On-line přístup:	https://doi.org/10.1007/s00277-026-07005-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!